CDR-Life, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, has completed its Series A financing raising USD 76 million. The round was led by Jeito Capital and RA Capital
Tags :Lars Schöni
Sonova Holding, a provider of audio solutions, entered into an agreement with Sennheiser electronic & Co. to acquire Sennheiser’s Consumer Division. The Sennheiser Consumer Division, which concentrates on the business of headphones and hearables
Bosch Service Solutions, a provider of technology-based services, has planned to acquire Elpro Group, headquartered in Buchs, Switzerland. Founded in 1986, Elpro Group develops monitoring solutions for the pharmaceutical, biotech, life science and healthcare industries. With
CSL Limited, a global biotechnology company based in Australia and Vifor Pharma, a Swiss-based global pharmaceutical company, entered into an agreement for CSL to launch an all-cash public tender offer to acquire all publicly held
